COHANCE LIFESCIENCES LTD Quarterly Results (COHANCE) — Q1 FY27

Revenue trend and demand read-through

Topline for Q1 FY27 came in at ₹422 cr against ₹549 cr in Q1 FY26, and ₹619 cr in the preceding Q4 FY26 quarter.

On a sequential basis revenue declined -31.8%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.

Total expenses for the quarter were ₹471 cr, or 111.5% of revenue, with operating profit declined -172.3% year on year.

Margins, tax and profitability

Net profit of -₹24.12 cr works out to a net margin of -5.7% compared with 8.9% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.

Below the operating line, COHANCE LIFESCIENCES LTD reported profit before tax of -₹42.87 cr, a tax charge of ₹2.32 cr (effective rate -5.4%), interest cost of ₹6.74 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.

Sequentially, net profit moved from ₹19.55 cr in Q4 FY26 to -₹24.12 cr in Q1 FY27, a change of -223.4%.

Trailing twelve months and annual context

Across the trailing four quarters COHANCE LIFESCIENCES LTD has generated revenue of ₹2,142 cr and net profit of ₹106 cr, a trailing net margin of 5.0%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.

On a full-year basis, FY26 revenue was ₹2,204 cr with net profit of ₹179 cr and EPS of ₹4.69, versus the prior year where revenue declined -12.8% and profit declined -63.2%.

What to watch in the next COHANCE quarter

For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.

COHANCE LIFESCIENCES LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.

All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.